Neoadjuvant cisplatin plus temozolomide versus standard treatment in patients with unresectable glioblastoma or anaplastic astrocytoma: a differential effect of MGMT methylation

Patterns of care and outcome for patients with glioblastoma diagnosed during 2008-2010 in Spain

(2013) F. Graus et al.   NEURO-ONCOLOGY

Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma

(2013) Emil Lou et al.   Cancer Medicine

Neoadjuvant treatment of breast cancer

(2012) A. M. Thompson et al.   ANNALS OF ONCOLOGY

Epidemiology of glial and non-glial brain tumours in Europe

(2012) Emanuele Crocetti et al.   EUROPEAN JOURNAL OF CANCER

Neoadjuvant Chemotherapy With Methotrexate, Cisplatin, and Doxorubicin With or Without Ifosfamide in Nonmetastatic Osteosarcoma of the Extremity: An Italian Sarcoma Group Trial ISG/OS-1

(2012) Stefano Ferrari et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognosis of patients with multifocal glioblastoma: a case-control study

(2012) Chirag G. Patil et al.   JOURNAL OF NEUROSURGERY

Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial

(2012) Annika Malmström et al.   LANCET ONCOLOGY

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

(2012) Wolfgang Wick et al.   LANCET ONCOLOGY

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005-2009

(2012) T. A. Dolecek et al.   NEURO-ONCOLOGY

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

(2010) Christian Hartmann et al.   ACTA NEUROPATHOLOGICA

Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004

(2010) L. Bauchet et al.   NEURO-ONCOLOGY

Patterns of Care and Survival in a Retrospective Analysis of 1059 Patients With Glioblastoma Multiforme Treated Between 2002 and 2007: A Multicenter Study by the Central Nervous System Study Group of Airo (Italian Association of Radiation Oncology)

(2010) Silvia Scoccianti et al.   NEUROSURGERY

Phase II Study of Neoadjuvant Imatinib in Glioblastoma: Evaluation of Clinical and Molecular Effects of the Treatment

(2009) E. Razis et al.   CLINICAL CANCER RESEARCH

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

Phase II preradiation R115777 (tipifarnib) in newly diagnosed GBM with residual enhancing disease

(2008) Robert Lustig et al.   NEURO-ONCOLOGY